Cakmak ME, Oztop N, Yegit OO, Ozdedeoglu O, et al. Evaluation of the Clinical Features and Laboratory Data of Patients with Severe Eosinophilic Asthma Classified as Super-Responders, Partial Responders, or Nonresponders to Mepolizumab Treatment: A Real-Life Study. Int Arch Allergy Immunol 2023 Mar 30:1-8. doi: 10.1159/000529760.
PMID: 36996772